Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) — Cash Flow Reinvestment Rate
Latest as of March 2020:
0.00x
Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $503.92K. See free cash flow generation of Eupraxia Pharmaceuticals Inc. Common Sto to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$503.92K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Eupraxia Pharmaceuticals Inc. Common Stock (None–None)
Year-by-year capital reinvestment analysis for Eupraxia Pharmaceuticals Inc. Common Stock. See how financially flexible is Eupraxia Pharmaceuticals Inc. Common Sto to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow